Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001753926-25-001500
Filing Date
2025-09-16
Accepted
2025-09-16 16:10:55
Documents
41
Period of Report
2025-09-16
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A g084946_8-ka.htm   iXBRL 8-K/A 998642
2 EXHIBIT 10.5 g084946_ex10-5.htm EX-10.5 337521
3 EXHIBIT 10.6 g084946_ex10-6.htm EX-10.6 29514
4 EXHIBIT 10.7 g084946_ex10-7.htm EX-10.7 76048
5 EXHIBIT 10.8 g084946_ex10-8.htm EX-10.8 219789
6 EXHIBIT 10.9 g084946_ex10-9.htm EX-10.9 29461
7 EXHIBIT 10.10 g084946_ex10-10.htm EX-10.10 118575
8 EXHIBIT 10.11 g084946_ex10-11.htm EX-10.11 15381
9 EXHIBIT 10.12 g084946_ex10-12.htm EX-10.12 26737
10 EXHIBIT 10.13 g084946_ex10-13.htm EX-10.13 28020
11 EXHIBIT 10.14 g084946_ex10-14.htm EX-10.14 13048
12 EXHIBIT 10.15 g084946_ex10-15.htm EX-10.15 20198
13 EXHIBIT 10.16 g084946_ex10-16.htm EX-10.16 21388
14 EXHIBIT 10.17 g084946_ex10-17.htm EX-10.17 18753
15 EXHIBIT 10.18 g084946_ex10-18.htm EX-10.18 586109
16 EXHIBIT 10.19 g084946_ex10-19.htm EX-10.19 101031
17 EXHIBIT 10.20 g084946_ex10-20.htm EX-10.20 58061
18 EXHIBIT 10.21 g084946_ex10-21.htm EX-10.21 326418
19 EXHIBIT 10.22 g084946_ex10-22.htm EX-10.22 161336
20 EXHIBIT 10.23 g084946_ex10-23.htm EX-10.23 209855
21 EXHIBIT 10.24 g084946_ex10-24.htm EX-10.24 188319
22 EXHIBIT 99.1 g084946_ex99-1.htm EX-99.1 227061
23 EXHIBIT 99.2 g084946_ex99-2.htm EX-99.2 327264
24 GRAPHIC img001.jpg GRAPHIC 5298
25 GRAPHIC img002.jpg GRAPHIC 3598
26 GRAPHIC img003.jpg GRAPHIC 25634
27 GRAPHIC img006.jpg GRAPHIC 93033
28 GRAPHIC img007.jpg GRAPHIC 12133
29 GRAPHIC img008.jpg GRAPHIC 7308
30 GRAPHIC img009.jpg GRAPHIC 7676
  Complete submission text file 0001753926-25-001500.txt   5285888

Data Files

Seq Description Document Type Size
31 XBRL SCHEMA FILE pths-20250916.xsd EX-101.SCH 3011
32 XBRL LABEL FILE pths-20250916_lab.xml EX-101.LAB 34239
33 XBRL PRESENTATION FILE pths-20250916_pre.xml EX-101.PRE 22356
43 EXTRACTED XBRL INSTANCE DOCUMENT g084946_8-ka_htm.xml XML 4267
Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41964 | Film No.: 251317440
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)